Insider Purchases: Inside the Buy

Tag: Cardiovascular

Boston Scientific (BSX) investment illustration featuring a heart, stock chart recovery, CEO insider buying, 0.71 PEG ratio, $3.7 billion free cash flow, and institutional ownership highlighting a long-term healthcare investment opportunity.

🫀 Boston Scientific (BSX): The CEO Just Bought $9 Million. Is Wall Street Missing Something?

Boston Scientific's stock has been cut nearly in half from its peak, yet the business remains fundamentally strong. With CEO Mike Mahoney buying $9 million worth of shares, a remarkably low 0.71 PEG ratio, billions in annual free cash flow, and overwhelming institutional ownership, is Wall Street overlooking one of healthcare's most attractive GARP opportunities?

Read entire article

Tags: Boston Scientific, BostonScientific, BSX, buy or sell BSX, Cardiovascular, CEO BUYS BSX, CEO Insider Buying, FARAPULSE, featured-insiders, Free Cash Flow, FUNanc1al, GARP, Growth Stocks, Healthcare Stocks, hub-insiders, hub-value, Insider Purchases, InsiderBuying, Long-Term Investing, Medical Devices, MedicalDevices, MedTech, Michael Mahoney, MikeMahoney, NYSE BSX, PEG Ratio, risks buying BSX, Stock Analysis, Value Investing, ValueInvesting, WATCHMAN, why buy BSX